venBio Partners

Latest statistics and disclosures from venBio Partners's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PHVS, ALMS, ALXO, HRMY, LYEL, and represent 98.13% of venBio Partners's stock portfolio.
  • Added to shares of these 1 stock: PHVS (+$8.7M).
  • venBio Partners was a net buyer of stock by $8.7M.
  • venBio Partners has $176M in assets under management (AUM), dropping by 53.72%.
  • Central Index Key (CIK): 0001776382

Tip: Access up to 7 years of quarterly data

Positions held by venBio Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for venBio Partners

venBio Partners holds 6 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pharvaris N V (PHVS) 65.6 $116M +8% 4.6M 24.95
 View chart
Alumis (ALMS) 10.4 $18M 4.6M 3.99
 View chart
Alx Oncology Hldgs (ALXO) 10.1 $18M 9.7M 1.83
 View chart
Harmony Biosciences Hldgs In (HRMY) 7.6 $14M 489k 27.56
 View chart
Lyell Immunopharma Com New (LYEL) 4.4 $7.7M 474k 16.24
 View chart
Artiva Biotherapeutics (ARTV) 1.9 $3.3M 1.1M 2.87
 View chart

Past Filings by venBio Partners

SEC 13F filings are viewable for venBio Partners going back to 2019

View all past filings